TABLE II.
Groups to identify | Proposed predictor |
P value (log likelihood) |
Area under the ROC curve |
---|---|---|---|
Asthmatic patients (all) vs healthy control subjects | Phospho-STAT1 | <10−4 | 0.95 |
Phospho-STAT6 | <10−4 | 0.89 | |
Phospho-STAT1 × Phospho-STAT6 | <10−4 | 0.96 | |
AA (all) vs NA (all) | Phospho-STAT1 | .001 | 0.91 |
Phospho-STAT6 | .024 | 0.69 | |
Phospho-STAT1 × Phospho-STAT6 | .015 | 0.91 | |
Plasma IgE | <10−4 | 1.00 | |
Plasma IL-4 | .021 | 0.80 | |
Asthmatic patients not taking OCSs vs asthmatic | Phospho-STAT1 | .77 | 0.61 |
patients taking OCSs | Phospho-STAT6 | .005 | 0.82 |
Phospho-STAT1 × Phospho-STAT6 | <10−4 | 1.00 | |
Plasma IgE | .015 | 0.82 | |
Plasma IL-4 | .013 | 0.65 |
See DeLong et al.33
AA, Allergic asthmatic patients; NA, nonallergic asthmatic patients.